Adam vetus tandem laetus novum promat canticum : Adán de San Víctor y la novedad del canto victorino en la lírica mariana medieval

La poesía latina del maestro Adán de San Víctor (ca.11121192), oriundo de Bretaña y canónigo agustino de la abadía parisina de SaintVictor, representa, en su ámbito y en su época, una novedad trascendente dentro de la lírica litúrgica y particularmente de la lírica mariana. La ductilidad rítmica y retórica del subgénero de la sequentia lograda en sus piezas hace de este autor un paradigma de la creación poética litúrgica en la Europa de los siglos XII y XIII. En este sentido, tanto la mención a su obra como la inclusión de sus sequentiae (junto con otras del mismo período y "estilo" gótico) en diversos manuscritos hispánicos, desde las Cantigas de Santa María hasta el ms. Alcobacense 149, permiten considerar la relevante influencia de esta refinada lírica del siglo XII en la confección de poemas y compilaciones marianas del siglo siguiente en la Península Ibérica.

Adam vetus tandem laetus novum promat canticum : Adán de San Víctor y la novedad del canto victorino en la lírica mariana medieval

La poesía latina del maestro Adán de San Víctor (ca.11121192), oriundo de Bretaña y canónigo agustino de la abadía parisina de SaintVictor, representa, en su ámbito y en su época, una novedad trascendente dentro de la lírica litúrgica y particularmente de la lírica mariana. La ductilidad rítmica y retórica del subgénero de la sequentia lograda en sus piezas hace de este autor un paradigma de la creación poética litúrgica en la Europa de los siglos XII y XIII. En este sentido, tanto la mención a su obra como la inclusión de sus sequentiae (junto con otras del mismo período y "estilo" gótico) en diversos manuscritos hispánicos, desde las Cantigas de Santa María hasta el ms. Alcobacense 149, permiten considerar la relevante influencia de esta refinada lírica del siglo XII en la confección de poemas y compilaciones marianas del siglo siguiente en la Península Ibérica.

Consulta sobre el Marquesado y Mayorazgo de Almuña y sus acrecentamientos y quien sea el legitimo sucessor por muerte del señor Don Francisco Centurion y Cordova que lo gozo por... cession del señor Marques de Estepa Don Adam... [Texto impreso]

Texto fechado en Estepa el 3 de agosto de 1677

Aplicabilidade de teoria do desvio de poder no controle da constitucionalidade de atos legislativos / Manoel Adam Lacayo Valente. --

Inclui notas explicativas, bibliográficas e bibliografia.

Clausula de convalidação em medidas provisorias / Manoel Adam Lacayo Valente. --

Inclui bibliografia.

The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: Neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis

Huntington's disease (HD) is a neurodegenerative disease caused by polyglutamine expansion in the protein huntingtin (htt). Pathogenesis in HD appears to involve the formation of ubiquitinated neuronal intranuclear inclusions containing N-terminal mutated htt, abnormal protein interactions, and the aggregate sequestration of a variety of proteins (noticeably, transcription factors). To identify novel htt-interacting proteins in a simple model system, we used a yeast two-hybrid screen with a Caenorhabditis elegans activation domain library. We found a predicted WW domain protein (ZK1127.9) that interacts with N-terminal fragments of htt in two-hybrid tests. A human homologue of ZK1127.9 is CA150, a transcriptional coactivator with a N-terminal insertion that contains an imperfect (Gln-Ala)38 tract encoded by a polymorphic repeat DNA. CA150 interacted in vitro with full-length htt from lymphoblastoid cells. The expression of CA150, measured immunohistochemically, was markedly increased in human HD brain tissue compared with normal age-matched human brain tissue, and CA150 showed aggregate formation with partial colocalization to ubiquitin-positive aggregates. In 432 HD patients, the CA150 repeat length explains a small, but statistically significant, amount of the variability in the onset age. Our data suggest that abnormal expression of CA150, mediated by interaction with polyglutamine-expanded htt, may alter transcription and have a role in HD pathogenesis.

Sequence-Specific Interaction between the Disintegrin Domain of Mouse ADAM 3 and Murine Eggs: Role of β1 Integrin-associated Proteins CD9, CD81, and CD98

ADAM 3 is a sperm surface glycoprotein that has been implicated in sperm-egg adhesion. Because little is known about the adhesive activity of ADAMs, we investigated the interaction of ADAM 3 disintegrin domains, made in bacteria and in insect cells, with murine eggs. Both recombinant proteins inhibited sperm-egg binding and fusion with potencies similar to that which we recently reported for the ADAM 2 disintegrin domain. Alanine scanning mutagenesis revealed a critical importance for the glutamine at position 7 of the disintegrin loop. Fluorescent beads coated with the ADAM 3 disintegrin domain bound to the egg surface. Bead binding was inhibited by an authentic, but not by a scrambled, peptide analog of the disintegrin loop. Bead binding was also inhibited by the function-blocking anti-α6 monoclonal antibody (mAb) GoH3, but not by a nonfunction blocking anti-α6 mAb, or by mAbs against either the αv or β3 integrin subunits. We also present evidence that in addition to the tetraspanin CD9, two other β1-integrin-associated proteins, the tetraspanin CD81 as well as the single pass transmembrane protein CD98 are expressed on murine eggs. Antibodies to CD9 and CD98 inhibited in vitro fertilization and binding of the ADAM 3 disintegrin domain. Our findings are discussed in terms of the involvement of multiple sperm ADAMs and multiple egg β1 integrin-associated proteins in sperm-egg binding and fusion. We propose that an egg surface “tetraspan web” facilitates fertilization and that it may do so by fostering ADAM–integrin interactions.

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10

Biochemical, epidemiological, and genetic findings demonstrate a link between cholesterol levels, processing of the amyloid precursor protein (APP), and Alzheimer's disease. In the present report, we identify the α-secretase ADAM 10 (a disintegrin and metalloprotease) as a major target of the cholesterol effects on APP metabolism. Treatment of various peripheral and neural cell lines with either the cholesterol-extracting agent methyl-β-cyclodextrin or the hydroxymethyl glutaryl-CoA reductase inhibitor lovastatin resulted in a drastic increase of secreted α-secretase cleaved soluble APP. This strong stimulatory effect was in the range obtained with phorbol esters and was further increased in cells overexpressing ADAM 10. In cells overexpressing APP, the increase of α-secretase activity resulted in a decreased secretion of Aβ peptides. Several mechanisms were elucidated as being the basis of enhanced α-secretase activity: increased membrane fluidity and impaired internalization of APP were responsible for the effect observed with methyl-β-cyclodextrin; treatment with lovastatin resulted in higher expression of the α-secretase ADAM 10. Our results demonstrate that cholesterol reduction promotes the nonamyloidogenic α-secretase pathway and the formation of neuroprotective α-secretase cleaved soluble APP by several mechanisms and suggest approaches to prevention of or therapy for Alzheimer's disease.